ÁßÁõ Àç»ýºÒ·®¼º ºóÇ÷¿¡ ´ëÇÑ µ¿Á¾°ñ¼öÀÌ½Ä ÈÄ¿¡ ¹ß»ýÇÑ ±âÁõ¼¼Æ÷¹éÇ÷º´ 1¿¹
A Case of Donor Cell Leukemia after Allogenic Bone Marrow Transplantation for Severe Aplastic Anemia

´ëÇѳ»°úÇÐȸÁö 2014³â 86±Ç 4È£ p.510 ~ p.514

±èÀºÁ¤(Kim Eun-Jeong) - °í½Å´ëÇб³º¹À½º´¿ø Ç÷¾×³»°ú
±è¾ç¼ö(Kim Yang-Soo) - °í½Å´ëÇб³º¹À½º´¿ø Ç÷¾×³»°ú
ÀÌÈ£¼·(Lee Ho-Seop) - °í½Å´ëÇб³º¹À½º´¿ø Ç÷¾×³»°ú
ÀÌÀº¹Ì(Lee Eun-Mi) - °í½Å´ëÇб³º¹À½º´¿ø Ç÷¾×³»°ú
¹ÚÀÌõ(Park I-Cheon) - °í½Å´ëÇб³º¹À½º´¿ø Ç÷¾×³»°ú
ÀÌ¿øÇü(Lee Weon-Hyoung) - °í½Å´ëÇб³º¹À½º´¿ø Ç÷¾×³»°ú
±è¹ÌÇâ(Kim Mi-Hyang) - °í½Å´ëÇб³º¹À½º´¿ø Áø´Ü°Ë»çÀÇÇаú

Abstract

Globally, there have been a small number of donor cell leukemia cases reported but, to our knowledge, none have been reported in Korea until now. Donor cell leukemia is a rare though well-recognized complication that occurs after allogenic hematopoietic stem cell transplantation (allo-HSCT). Herein, we report the case of an 18-year-old woman who developed acute lymphoblastic leukemia originating from donor cells after allo-HSCT

Ű¿öµå

Leukemia, Anemia, aplastic, Bone marrow transplantation
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸
ÇмúÁøÈïÀç´Ü(KCI) KoreaMed ´ëÇÑÀÇÇÐȸ ȸ¿ø 
ÁÖÁ¦ÄÚµå
ÁÖÁ¦¸í(Target field)
¿¬±¸´ë»ó(Population)
¿¬±¸Âü¿©(Sample size)
´ë»ó¼ºº°(Gender)
Áúº´Æ¯¼º(Condition Category)
¿¬±¸È¯°æ(Setting)
¿¬±¸¼³°è(Study Design)
¿¬±¸±â°£(Period)
ÁßÀç¹æ¹ý(Intervention Type)
ÁßÀç¸íĪ(Intervention Name)
Ű¿öµå(Keyword)
À¯È¿¼º°á°ú(Recomendation)
¿¬±¸ºñÁö¿ø(Fund Source)
±Ù°Å¼öÁØÆò°¡(Evidence Hierarchy)
ÃâÆÇ³âµµ(Year)
Âü¿©ÀúÀÚ¼ö(Authors)
´ëÇ¥ÀúÀÚ
DOI
KCDÄÚµå
ICD 03
°Ç°­º¸ÇèÄÚµå